Ara
Toplam kayıt 1, listelenen: 1-1
Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML
(2015)
Unsustainable drug prices in chronic myeloid leukemia (CML) and cancer may be causing harm to patients. The aim of this multi-center study is to assess the efficacy of generic imatinib mesylate (IM) over Glivec in terms ...